Adverum Biotechnologies
ADVM
$2.47
Share price
-6.79%
Change (1 day)
-67.33%
Change (1 year)
Earnings for Adverum Biotechnologies (ADVM)
Earnings in 2025 (TTM): -$0.16 Billion USD
According to Adverum Biotechnologies 's latest financial reports the company's current earnings are $1 Million USD. In 2024 the company made an earning of -$0.14 Billion USD a decrease over its 2023 earnings that were of -$0.12 Billion USD. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Adverum Biotechnologies from 2013 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | -$0.16 Billion | 14.91% |
| 2024 | -$0.14 Billion | 12.72% |
| 2023 | -$0.12 Billion | -23.45% |
| 2022 | -$0.16 Billion | 6.13% |
| 2021 | -$0.15 Billion | 25.04% |
| 2020 | -$0.12 Billion | 80.49% |
| 2019 | -$64.49 Million | -12.71% |
| 2018 | -$73.88 Million | 31.58% |
| 2017 | -$56.15 Million | -50.97% |
| 2016 | -$0.12 Billion | 141.34% |
| 2015 | -$47.46 Million | 86.79% |
| 2014 | -$25.41 Million | 381.5% |
| 2013 | -$5.28 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.15 Billion | -4.27% | 🇺🇸 USA |